Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Thu, 28th May 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES BURBERRY PRICE TARGET TO 983 (959) PENCE - 'SELL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1380 (1225) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN TARGET TO 2440 (2400) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS BRITISH LAND CO PRICE TARGET TO 475 (550) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES M&G PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 1520 (1470) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES CRODA INTERNATIONAL TARGET TO 4100 (3900) PENCE - 'UNDERPERFORM'

----------

FTSE 250

----------

JEFFERIES INITIATES GREGGS WITH 'BUY' - TARGET 2375 PENCE

----------

JEFFERIES INITIATES GAMES WORKSHOP GROUP WITH 'BUY' - TARGET 8500 PENCE

----------

JEFFERIES RAISES BRITVIC PRICE TARGET TO 850 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 500 (575) PENCE - 'BUY'

----------

LIBERUM RAISES PAYPOINT PRICE TARGET TO 1000 (800) PENCE - 'BUY'

----------

DAVY RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERPERFORM')

----------

BARCLAYS CUTS TATE & LYLE PRICE TARGET TO 730 (800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PROVIDENT FINANCIAL TARGET TO 405 (510) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES HAYS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 120 (105) P

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 195 (210) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS DAILY MAIL PRICE TARGET TO 800 (950) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 708 (757) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLINIGEN PRICE TARGET TO 1050 (850) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

Read more
23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

Read more
16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

Read more
9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

IN BRIEF: Clinigen signs global distribution deal for Qinlock

Read more
8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

Read more
17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

Triton increases takeover bid for Clinigen to GBP1.3 billion

Read more
17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

Read more
12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

Read more
12 Jan 2022 11:13

Clinigen holds earnings growth guidance after solid first half

Clinigen holds earnings growth guidance after solid first half

Read more
11 Jan 2022 14:59

CORRECT: UK shareholder meetings calendar - next 7 days

CORRECT: UK shareholder meetings calendar - next 7 days

Read more
11 Jan 2022 14:46

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Dec 2021 15:55

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
8 Dec 2021 11:56

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.